New perspectives in the management of diabetic nephropathy

doi:10.4239/wjd.v15.i6.1086

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1193)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

950

Sum=990

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=135

Jun 15, 2024 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Diabetes. Jun 15, 2024; 15(6): 1086-1090
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1086

New perspectives in the management of diabetic nephropathy

Anna Psyllaki, Konstantinos Tziomalos

Anna Psyllaki, Konstantinos Tziomalos, The First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece

Author contributions: Psyllaki A drafted the manuscript; Tziomalos K critically revised the draft.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Konstantinos Tziomalos, MD, MSc, PhD, Associate Professor, The First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 Stilponos Kyriakidi Street, Thessaloniki 54636, Greece. ktziomalos@yahoo.com

Received: January 7, 2024
Revised: February 1, 2024
Accepted: March 25, 2024
Published online: June 15, 2024
Processing time: 156 Days and 6.4 Hours

Core Tip

Core Tip: The management of diabetic nephropathy evolved substantially in recent years with the accumulation of evidence showing that sodium-glucose cotransporter 2 inhibitors and potentially finerenone prevent both renal function deterioration and cardiovascular events.